BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33406229)

  • 1. Recombinant Thrombomodulin Attenuates Preeclamptic Symptoms by Inhibiting High-Mobility Group Box 1 in Mice.
    Oda H; Nagamatsu T; Schust DJ; Cabral H; Miyazaki T; Iriyama T; Kawana K; Osuga Y; Fujii T
    Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33406229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis.
    Watanabe E; Akamatsu T; Ohmori M; Kato M; Takeuchi N; Ishiwada N; Nishimura R; Hishiki H; Fujimura L; Ito C; Hatano M
    Cytokine; 2022 Jan; 149():155723. PubMed ID: 34662822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombomodulin promotes placental function by up-regulating placental growth factor via inhibition of high-mobility-group box 1 and hypoxia-inducible factor 1α.
    Oda H; Nagamatsu T; Cabral H; Miyazaki T; Iriyama T; Kawana K; Fujii T; Osuga Y
    Placenta; 2021 Aug; 111():1-9. PubMed ID: 34126415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
    Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
    Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered release of thrombomodulin and HMGB1 in the placenta complicated with preeclampsia.
    Oda H; Nagamatsu T; Iriyama T; Osuga Y
    Placenta; 2024 Mar; 148():12-19. PubMed ID: 38330539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome.
    Kudo D; Toyama M; Aoyagi T; Akahori Y; Yamamoto H; Ishii K; Kanno E; Maruyama R; Kaku M; Kushimoto S; Kawakami K
    Clin Exp Immunol; 2013 Aug; 173(2):276-87. PubMed ID: 23607598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Kuwabara S
    Clin Exp Immunol; 2018 Jul; 193(1):47-54. PubMed ID: 29509323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model.
    Hirao S; Minakata K; Masumoto H; Yamazaki K; Ikeda T; Minatoya K; Sakata R
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):1973-1983.e1. PubMed ID: 28645823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats.
    Hirakawa Y; Tsuchishima M; Fukumura A; Kinoshita K; Hayashi N; Saito T; George J; Toshikuni N; Ueda Y; Tsutsumi M
    Eur J Pharmacol; 2019 Nov; 863():172681. PubMed ID: 31542482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice.
    Takahashi Y; Matsutani N; Dejima H; Nakayama T; Okamura R; Uehara H; Kawamura M
    J Trauma Acute Care Surg; 2016 Nov; 81(5):868-875. PubMed ID: 27504958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure.
    Kurokohchi K; Imataki O; Kubo F
    World J Gastroenterol; 2015 Jul; 21(26):8203-7. PubMed ID: 26185395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin and pregnancy in the limelight: Insights into the therapeutic aspect of thrombomodulin in pregnancy complications.
    Oda H; Nagamatsu T; Osuga Y
    J Thromb Haemost; 2022 May; 20(5):1040-1055. PubMed ID: 35191182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble recombinant human thrombomodulin suppresses inflammation-induced gastrointestinal tumor growth in a murine peritonitis model.
    Amada E; Fukuda K; Kumagai K; Kawakubo H; Kitagawa Y
    Mol Cell Biochem; 2020 Dec; 475(1-2):195-203. PubMed ID: 32767229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition.
    Ueda T; Higashiyama M; Narimatsu K; Yasutake Y; Kurihara C; Okada Y; Watanabe C; Yoshikawa K; Maruta K; Komoto S; Tomita K; Nagao S; Hokari R; Miura S
    Digestion; 2015; 92(2):108-19. PubMed ID: 26302768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin as an intravascular safeguard against inflammatory and thrombotic diseases.
    Ito T; Kakihana Y; Maruyama I
    Expert Opin Ther Targets; 2016; 20(2):151-8. PubMed ID: 26558419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
    Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.
    Zhou CC; Irani RA; Dai Y; Blackwell SC; Hicks MJ; Ramin SM; Kellems RE; Xia Y
    J Immunol; 2011 May; 186(10):6024-34. PubMed ID: 21482739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.